SEOM Clinical Guideline in ovarian cancer (2016)

被引：19
|
作者：
Santaballa, A. [1 ]
Barretina, P. [2 ]
Casado, A. [3 ]
Garcia, Y. [4 ]
Gonzalez-Martin, A. [5 ]
Guerra, E. [6 ]
Lainez, N. [7 ]
Martinez, J. [8 ]
Redondo, A. [9 ]
Romero, I. [10 ]
机构：
[1] Hosp Univ & Politecn La Fe, Serv Oncol Med, Avda Fernando Abril Martorell 106, Valencia 46026, Spain
[2] Inst Catala Oncol, Serv Oncol Med, Girona, Spain
[3] Hosp Clin Univ, Serv Oncol Med, Madrid, Spain
[4] Corp Sanitaria Parc Tauli, Serv Oncol Med, Sabadell, Spain
[5] MD Anderson Canc Ctr, Serv Oncol Med, Madrid, Spain
[6] Hosp Univ Ramon & Cajal, Serv Oncol Med, Madrid, Spain
[7] Complejo Hosp Navarra, Serv Oncol Med, Pamplona, Spain
[8] Hosp Univ Virgen de la Arrixaca, Serv Oncol Med, Murcia, Spain
[9] Hosp Univ La Paz, Serv Oncol Med, Madrid, Spain
[10] Fdn Inst Valenciano Oncol, Serv Oncol Med, Valencia, Spain
来源：
CLINICAL & TRANSLATIONAL ONCOLOGY | 2016年 / 18卷 / 12期
关键词：
Ovarian cancer; Treatment guidelines; First line; Recurrent disease; PHASE-III TRIAL; PEGYLATED LIPOSOMAL DOXORUBICIN; RANDOMIZED-TRIAL; OPEN-LABEL; EXPLORATORY ANALYSIS; EPITHELIAL OVARIAN; PRIMARY PERITONEAL; PRIMARY SURGERY; FALLOPIAN-TUBE; CHEMOTHERAPY;
D O I：
10.1007/s12094-016-1588-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite remarkable advances in the knowledge of molecular biology and treatment, ovarian cancer (OC) is the first cause of death due to gynecological cancer and the fifth cause of death for cancer in women in Spain. The aim of this guideline is to summarize the current evidence and to give evidence-based recommendations for clinical practice.
引用
收藏
页码：1206 / 1212
页数：7
相关论文
共 50 条
  • [31] SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)
    Alonso-Gordoa, Teresa
    Jimenez-Fonseca, Paula
    Martinez-Trufero, Javier
    Navarro, Miguel
    Porras, Ignacio
    Rubio-Casadevall, Jordi
    Arregui Valles, Marta
    Baste, Neus
    Hernando, Jorge
    Iglesias Docampo, Lara
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (11) : 2902 - 2916
  • [32] Systemic therapy for recurrent epithelial ovarian cancer: a clinical practice guideline
    Francis, J.
    Coakley, N.
    Elit, L.
    Mackay, H.
    CURRENT ONCOLOGY, 2017, 24 (06) : E540 - E546
  • [33] SEOM clinical guidelines in hereditary breast and ovarian cancer (2019)
    Gonzalez-Santiago, S.
    Ramon y Cajal, T.
    Aguirre, E.
    Ales-Martinez, J. E.
    Andres, R.
    Balmana, J.
    Grana, B.
    Herrero, A.
    Llort, G.
    Gonzalez-del-Alba, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (02) : 193 - 200
  • [34] SEOM clinical guidelines in hereditary breast and ovarian cancer (2019)
    S. González-Santiago
    T. Ramón y Cajal
    E. Aguirre
    J. E. Alés-Martínez
    R. Andrés
    J. Balmaña
    B. Graña
    A. Herrero
    G. Llort
    A. González-del-Alba
    Clinical and Translational Oncology, 2020, 22 : 193 - 200
  • [35] Therapie strategies for the recurrence of ovarian cancer
    Delarue, E.
    Rohr, I.
    Sehouli, J.
    ONKOLOGE, 2014, 20 (07): : 674 - 678
  • [36] SEOM-SOGUG clinical guideline for localized muscle invasive and advanced bladder cancer (2021)
    Valderrama, Begona P.
    Gonzalez-del-Alba, Aranzazu
    Morales-Barrera, Rafael
    Pelaez Fernandez, Ignacio
    Vazquez, Sergio
    Caballero Diaz, Cristina
    Domenech, Montserrat
    Fernandez Calvo, Ovidio
    de Liano Lista, Alfonso Gomez
    Arranz Arija, Jose Angel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24 (04) : 613 - 624
  • [37] SEOM clinical guidelines in metastatic breast cancer 2015
    Gavila, J.
    Lopez-Tarruella, S.
    Saura, C.
    Munoz, M.
    Oliveira, M.
    De la Cruz-Merino, L.
    Morales, S.
    Alvarez, I.
    Virizuela, J. A.
    Martin, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12) : 946 - 955
  • [38] SEOM clinical guidelines for the management of germ cell testicular cancer (2016)
    J. Aparicio
    J. Terrasa
    I. Durán
    J. R. Germà-Lluch
    R. Gironés
    E. González-Billalabeitia
    J. Gumà
    P. Maroto
    A. Pinto
    X. García-del-Muro
    Clinical and Translational Oncology, 2016, 18 : 1187 - 1196
  • [39] Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease
    Wilson, M. K.
    Pujade-Lauraine, E.
    Aoki, D.
    Mirza, M. R.
    Lorusso, D.
    Oza, A. M.
    du Bois, A.
    Vergote, I.
    Reuss, A.
    Bacon, M.
    Friedlander, M.
    Gallardo-Rincon, D.
    Joly, F.
    Chang, S. -J.
    Ferrero, A. M.
    Edmondson, R. J.
    Wimberger, P.
    Maenpaa, J.
    Gaffney, D.
    Zang, R.
    Okamoto, A.
    Stuart, G.
    Ochiai, K.
    ANNALS OF ONCOLOGY, 2017, 28 (04) : 727 - 732
  • [40] SEOM clinical guideline for the management of malignant melanoma (2017)
    Berrocal, A.
    Arance, A.
    Castellon, V. E.
    de la Cruz, L.
    Espinosa, E.
    Cao, M. G.
    Larriba, J. L. G.
    Marquez-Rodas, I.
    Soria, A.
    Algarra, S. M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (01) : 69 - 74
12345